Well spotted - Neuren engaging in the same sort of outreach to the PMS community as it did with Retts during stage 2 trials.
Ann: P2 trial shows significant improvements in Phelan-McDermid, page-209
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.22 |
Change
-0.260(1.68%) |
Mkt cap ! $1.940B | |||
| Open | High | Low | Value | Volume |
| $15.20 | $15.33 | $15.02 | $2.438M | 160.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 373 | $15.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.23 | 1568 | 13 |
View Market Depth
| Last trade - 11.25am 22/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |